Bio-Technology General sales and marketing update

BTGC signed two agreements for the marketing of BioLon, its ready-to-use syringe containing a 1 percent solution of sodium hyaluronate for use in ophthalmic surgeries. BTGC signed Inphormed Ltd. and M...